Loading...
VIS logo

Viscofan, S.A.BME:VIS Stock Report

Market Cap €2.7b
Share Price
€58.50
n/a
1Y-4.4%
7D-1.7%
Portfolio Value
View

Viscofan, S.A.

BME:VIS Stock Report

Market Cap: €2.7b

Viscofan (VIS) Stock Overview

Manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. More details

VIS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance3/6
Financial Health5/6
Dividends3/6

VIS Community Fair Values

Create Narrative

See what 36 others think this stock is worth. Follow their fair value or set your own to get alerts.

Viscofan, S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Viscofan
Historical stock prices
Current Share Price€58.50
52 Week High€68.70
52 Week Low€48.35
Beta0.18
1 Month Change3.91%
3 Month Change11.64%
1 Year Change-4.41%
3 Year Change-12.10%
5 Year Change3.82%
Change since IPO641.53%

Recent News & Updates

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Feb 11
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan, S.A. (BME:VIS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Oct 28
Viscofan, S.A. (BME:VIS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Recent updates

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Feb 11
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan, S.A. (BME:VIS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Oct 28
Viscofan, S.A. (BME:VIS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Viscofan (BME:VIS) Is Very Good At Capital Allocation

Sep 06
Viscofan (BME:VIS) Is Very Good At Capital Allocation

Viscofan, S.A.'s (BME:VIS) Share Price Could Signal Some Risk

Aug 02
Viscofan, S.A.'s (BME:VIS) Share Price Could Signal Some Risk

Viscofan, S.A. (BME:VIS) Just Reported Half-Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Aug 02
Viscofan, S.A. (BME:VIS) Just Reported Half-Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Jul 11
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Is Viscofan, S.A. (BME:VIS) Trading At A 29% Discount?

Jun 17
Is Viscofan, S.A. (BME:VIS) Trading At A 29% Discount?

The Viscofan, S.A. (BME:VIS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 01
The Viscofan, S.A. (BME:VIS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Is Now The Time To Put Viscofan (BME:VIS) On Your Watchlist?

Apr 28
Is Now The Time To Put Viscofan (BME:VIS) On Your Watchlist?

Risks To Shareholder Returns Are Elevated At These Prices For Viscofan, S.A. (BME:VIS)

Apr 14
Risks To Shareholder Returns Are Elevated At These Prices For Viscofan, S.A. (BME:VIS)

Analysts Are Updating Their Viscofan, S.A. (BME:VIS) Estimates After Its Yearly Results

Mar 02
Analysts Are Updating Their Viscofan, S.A. (BME:VIS) Estimates After Its Yearly Results

We Think Viscofan (BME:VIS) Can Stay On Top Of Its Debt

Jan 24
We Think Viscofan (BME:VIS) Can Stay On Top Of Its Debt

Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Dec 26
Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Analyst Estimates: Here's What Brokers Think Of Viscofan, S.A. (BME:VIS) After Its Third-Quarter Report

Oct 26
Analyst Estimates: Here's What Brokers Think Of Viscofan, S.A. (BME:VIS) After Its Third-Quarter Report

Estimating The Fair Value Of Viscofan, S.A. (BME:VIS)

Oct 08
Estimating The Fair Value Of Viscofan, S.A. (BME:VIS)

Viscofan, S.A.'s (BME:VIS) Popularity With Investors Is Under Threat From Overpricing

Sep 25
Viscofan, S.A.'s (BME:VIS) Popularity With Investors Is Under Threat From Overpricing

Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today

Aug 17
Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today

Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 02
Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Jun 26
Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apr 20
Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Apr 11
Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Apr 04
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Mar 18
Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Jan 17
Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Is Viscofan (BME:VIS) Using Too Much Debt?

Dec 21
Is Viscofan (BME:VIS) Using Too Much Debt?

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Nov 15
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 20
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Aug 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Aug 11
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

May 25
Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

May 04
Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Apr 24
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

The Returns At Viscofan (BME:VIS) Aren't Growing

Mar 02
The Returns At Viscofan (BME:VIS) Aren't Growing

Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Feb 16
Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Is Viscofan (BME:VIS) Using Too Much Debt?

Jan 07
Is Viscofan (BME:VIS) Using Too Much Debt?

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Nov 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Nov 11
Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 01
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Aug 03
Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Viscofan's (BME:VIS) Returns Have Hit A Wall

May 03
Viscofan's (BME:VIS) Returns Have Hit A Wall

Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Mar 25
Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Mar 06
Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Jan 15
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Dec 29
Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Shareholder Returns

VISES FoodES Market
7D-1.7%-0.6%-0.5%
1Y-4.4%-2.4%29.7%

Return vs Industry: VIS underperformed the Spanish Food industry which returned -2.4% over the past year.

Return vs Market: VIS underperformed the Spanish Market which returned 29.7% over the past year.

Price Volatility

Is VIS's price volatile compared to industry and market?
VIS volatility
VIS Average Weekly Movement2.3%
Food Industry Average Movement4.3%
Market Average Movement3.7%
10% most volatile stocks in ES Market6.7%
10% least volatile stocks in ES Market0.8%

Stable Share Price: VIS has not had significant price volatility in the past 3 months compared to the Spanish market.

Volatility Over Time: VIS's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19755,921Jose Canales Garciawww.viscofan.com

Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. The company offers cellulose, collagen, fibrous, functional solutions, plastics, viscofan veggie, efan, edileaf, nutra-pharma collinstant, nutra-pharma satiscoll, and medical. It also provides collagen casings for processed and pre-cooked fried sausages, and dry-cured snacks, as well as collagen film cover for meat products under the Total Control Net brand.

Viscofan, S.A. Fundamentals Summary

How do Viscofan's earnings and revenue compare to its market cap?
VIS fundamental statistics
Market cap€2.70b
Earnings (TTM)€159.92m
Revenue (TTM)€1.25b
16.8x
P/E Ratio
2.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIS income statement (TTM)
Revenue€1.25b
Cost of Revenue€445.19m
Gross Profit€806.79m
Other Expenses€646.87m
Earnings€159.92m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)3.48
Gross Margin64.44%
Net Profit Margin12.77%
Debt/Equity Ratio32.6%

How did VIS perform over the long term?

See historical performance and comparison

Dividends

3.8%
Current Dividend Yield
64%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/13 18:34
End of Day Share Price 2026/03/13 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Viscofan, S.A. is covered by 19 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
José RitoBanco BPI, S.A.
null nullBanco de Sabadell. S.A.
Manuel Lorente OrtegaBanco Santander